“There are a lot of opportunities out there, and one shouldn’t complain, unless you don’t have good health,” says Irving Kahn.
Irving Kahn Interview With CNN Money
No. 1: BristolMyers Squibb Co. (BMY), Weightings: 11.9004% - 1,610,881 Shares
Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. BristolMyers Squibb Co. has a market cap of $59.7 billion; its shares were traded at around $35.23 with a P/E ratio of 15.9 and P/S ratio of 3.1. The dividend yield of BristolMyers Squibb Co. stocks is 3.7%. BristolMyers Squibb Co. had an annual average earnings growth of 15% over the past 5 years.
No. 2: Pfizer Inc. (PFE), Weightings: 10.7755% - 2,588,862 Shares
Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer Inc. has a market cap of $167.35 billion; its shares were traded at around $21.77 with a P/E ratio of 9.5 and P/S ratio of 2.5. The dividend yield of Pfizer Inc. stocks is 3.7%. Pfizer Inc. had an annual average earnings growth of 1.2% over the past 10 years.
No. 3: New York Community Bancorp Inc. (NYB), Weightings: 10.1786% - 3,633,261 Shares
New York Community Bancorp, Inc. is a producer of multi-family loans in New York City, with an emphasis on apartment buildings that feature below-market rents. New York Community Bancorp Inc. has a market cap of $5.41 billion; its shares were traded at around $12.37 with a P/E ratio of 10 and P/S ratio of 2.4. The dividend yield of New York Community Bancorp Inc. stocks is 8.1%. New York Community Bancorp Inc. had an annual average earnings growth of 3.5% over the past 10 years.
No. 4: Merck & Co. Inc. (MRK), Weightings: 10.0811% - 1,309,532 Shares
Merck & Co. Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Merck & Co. Inc. has a market cap of $115.06 billion; its shares were traded at around $37.75 with a P/E ratio of 10.2 and P/S ratio of 2.5. The dividend yield of Merck & Co. Inc. stocks is 4.4%.
No. 5: Seaboard Corp. (SEB), Weightings: 6.461% - 15,230 Shares
Seaboard Corporation is a diversified international agribusiness and transportation company. Seaboard Corp. has a market cap of $2.53 billion; its shares were traded at around $2087.84 with a P/E ratio of 6.9 and P/S ratio of 0.6. Seaboard Corp. had an annual average earnings growth of 4.9% over the past 10 years.








RSS